David Maldonado in Newburgh, Indiana

Home Indiana Newburgh

David Maldonado has Nurse Practitioner as his primary medical specialty. Their primary office is: 4015 Gateway Blvd in Newburgh, Indiana. There is an additional office location, for a total of two, for David Maldonado that can be viewed further down.

They're a part of the: Deaconess Hospital Inc medical group which has around 327 members. You can call their office at 812-450-7720 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2021 (around 3 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

David K Maldonado Office Phone and Directions

David Maldonado
Deaconess Hospital Inc
4015 Gateway Blvd
Newburgh, Indiana 47630
812-450-7720

Patient Ratings
Please rate your experience with David Maldonado below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 812-450-7720

Enter a starting address:

Healthcare Info for David Maldonado

Medical School: Sorry, his university is not listed
Graduation Year: 2021
The Primary Medical Specialty for David Maldonado is listed as: Nurse Practitioner
Approximate Years of Experience: 3
PAC (PECOS ID)#: 1052717618
NPI #: 1336815356
NPI Created On: 08/19/2021
NPI Last Updated Listed as: 08/19/2021
Primary Taxonomy Code: 363LA2100X
License Number:
71011472A
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788132607

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30